Home › Funds › BRAIDWELL LP › MRVI

BRAIDWELL LP position in MRVI

MARAVAI LIFESCIENCES HLDGS I · Health Care

BRAIDWELL LP reported holding 8,702,921 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q2 2026 13F filing — a position valued at US$54.3M, representing 2.14% of its reported portfolio and ranking #14 among its reported holdings. BRAIDWELL LP has disclosed MRVI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)8.70M sh
Reported value held$54.31M
Portfolio Weight2.14%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's MRVI position evolved

BRAIDWELL LP first disclosed a stake in MRVI in Q3 2023 at 3,974,857 shares (US$39.7M). The position peaked in Q3 2024 at 8,353,287 shares, worth US$69.4M. Across 12 filings, BRAIDWELL LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 8,702,921 shares valued at US$54.3M — a reduction of -1,537,243 shares quarter over quarter.. Notable position changes include a 27% increase in Q4 2023 (shares rose 32% over the following quarter), a 43% increase in Q1 2024 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.97M $39.75M New
Q4 2023 5.04M $33.02M Add
Q1 2024 7.22M $62.61M Add
Q2 2024 9.02M $64.61M Add
Q3 2024 8.35M $69.42M Reduce
Q4 2024 8.35M $45.53M Hold
Q1 2025 8.35M $18.46M Hold
Q2 2025 8.35M $20.13M Hold
Q3 2025 8.35M $23.97M Hold
Q4 2025 8.35M $27.15M Hold
Q1 2026 10.24M $28.98M Add
Q2 2026 8.70M $54.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRVI and 13F data

MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 35 other funds we track also report a position in MRVI — the largest reported positions include GTCR LLC (US$125.7M), 12 West Capital Management LP (US$44.1M), Ophir Asset Management Pty Ltd (US$30.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRVI

All MRVI fund holders →

FAQ

How long has BRAIDWELL LP held MRVI?

BRAIDWELL LP has disclosed MRVI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BRAIDWELL LP's current position in MRVI?

As of Q2 2026, BRAIDWELL LP holds 8.70M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $54.31M, representing 2.14% of its reported portfolio and ranking #14.

Has BRAIDWELL LP been buying or selling MRVI?

In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in MRVI. The position peaked in Q3 2024 at 8.35M shares.

Which other funds hold MRVI?

Other major institutional holders of MRVI include GTCR LLC, 12 West Capital Management LP, Ophir Asset Management Pty Ltd, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.